3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Phase 2
1
Phase 1/2
1
Status
Terminated
1
Recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
9
OTHER
4
Study Type
Interventional
4
Sponsor
Cancer Type
Tumor-Agnostic
1
Sarcoma
1
Other hematologic neoplasm
1
Gastrointestinal
1
Conditions
Neoplasm Metastasis
2
Sarcoma
1
Leukemia, Myeloid, Acute
1
Colorectal Neoplasms
1
Interventions
Cyclophosphamide
2042
Radiotherapy
1859
Cisplatin
1825
Carboplatin
1533
Gemcitabine
1434
Paclitaxel
1289
Bevacizumab
1270
Docetaxel
1202
pembrolizumab
1199
Oxaliplatin
1160
Capecitabine
1144
Fluorouracil
1061
Dexamethasone
971
Rituximab
919
Nivolumab
908
Magnetic Resonance Spectroscopy
862
Etoposide
839
Doxorubicin
823
Drug Therapy
792
Radiosurgery
776
Irinotecan
775
Cytarabine
736
fludarabine
716
Leucovorin
676
Lenalidomide
608
fludarabine phosphate
564
Temozolomide
552
Radiation
541
Filgrastim
540
Cetuximab
537
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
OTHER
×
Interventional
×
siremadlin
×
Clear all
NCT04116541
2026-04-24
MegaMOST
Centre Leon Berard
Phase 2
Recruiting
455 enrolled
NCT05180695
2026-02-10
AMPHISARC
Centre Leon Berard
Phase 1/2
Active not recruiting
47 enrolled
NCT03714958
2023-09-13
TRAHD
Centre Leon Berard
Phase 1
Completed
12 enrolled
NCT04496999
2022-10-06
HDMM
Insel Gruppe AG, University Hospital Bern
Phase 1
Terminated
2 enrolled